, 2013), in alcohol-exposed astrocytes from organotypic hippocampal-entorhinal cortex brain slices, and hippocampal neurons of postmortem alcoholic selleck screening library human brain (Zou and Crews, 2012). However, there are more studies showing no detected NLRP3 protein in neurons (Silverman

et al., 2009), or spinal cord lysates from sham and traumatized animals (de Rivero Vaccari et al., 2008). In this study, we did not found co-location of NeuN and NLRP3 protein expression in PFC of both CUMS and Non-CUMS animals. In fact, CUMS procedure increased the activated microglia but not astrocyte in PFC of rats, being consistent with the activation of microglia detected in the condition of acute or chronic stress in CNS (Frank et al., 2012 and Sugama et al., 2007). More importantly, TSA HDAC cell line fluorescence immunohistochemistry revealed co-expression of NLRP3 and Iba1 protein in PFC of CUMS rats, further demonstrating the increased microglial activation in mice under chronic stress (Heneka et al., 2013). These findings raise the possibility that microglial NLRP3 inflammasome activation may mediate IL-1β-related CNS inflammation in CUMS rats. The hypothalamic–pituitary–adrenal axis (HPA) is a major part of the neuroendocrine system that controls reactions to stress and regulates mood and emotion. Hyperactivity of the HPA axis with the elevated

glucocorticoids levels is characteristic of the pathophysiology of MDD (Pariante and Lightman, 2008). Our previous studies demonstrated that CUMS procedure caused hyperactivity of the HPA axis and high levels of serum glucocorticoids in rats (Pan et al., 2006 and Pan et al., 2010). Recently, some studies have shown

that glucocorticoid pretreatment sensitizes inflammatory response in the CNS (Frank et al., 2011 and Frank et al., 2012), which is previously Sclareol considered as the events of glucocorticoid resistance in depression. Glucocorticoids dependently induce the NLRP3 mRNA and protein expression and mature IL-1β release (Busillo et al., 2011). Thus, CUMS procedure-activated PFC NLRP3 inflammasome may be a central mediator to develop depression with IL-1β-related CNS inflammation. This highlights the need for further study to prove the possible role of PFC NLRP3 inflammasome activation in pathological process of IL-1β-related CNS inflammation during chronic stress. Antidepressant fluoxetine is approved for use in treating MDD (Beasley et al., 2000). Recent study demonstrate that fluoxetine may shift the balance of inflammation toward anti-inflammatory state in rat hypothalamus (Alboni et al., 2013). In this study, fluoxetine treatment was further confirmed to restore CUMS-induced depressive-like behavior in rats. Moreover, it was found that fluoxetine treatment had the potential to ameliorate the CNS inflammation by decreasing expression and activity of PFC IL-1β in rats.